VRIO Analysis of Sarepta Therapeutics Inc
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Sarepta Therapeutics Inc will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Sarepta Therapeutics Inc VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Sarepta Therapeutics Inc VRIO Analysis shows that the financial resources of Sarepta Therapeutics Inc are highly valuable as these help in investing into external opportunities that arise. These also help Sarepta Therapeutics Inc in combating external threats.
- According to the VRIO Analysis of Sarepta Therapeutics Inc, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Sarepta Therapeutics Inc VRIO Analysis shows that Sarepta Therapeutics Inc's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Sarepta Therapeutics Inc's products.
- According to the VRIO Analysis of Sarepta Therapeutics Inc, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Sarepta Therapeutics Inc. These patents also provide Sarepta Therapeutics Inc with licensing revenue when it licenses these patents out to other manufacturers.
- The Sarepta Therapeutics Inc VRIO Analysis shows that Sarepta Therapeutics Inc’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Sarepta Therapeutics Inc. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Sarepta Therapeutics Inc, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Sarepta Therapeutics Inc VRIO Analysis shows that the research and development at Sarepta Therapeutics Inc is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Sarepta Therapeutics Inc. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Sarepta Therapeutics Inc are found to be rare according to the VRIO Analysis of Sarepta Therapeutics Inc. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Sarepta Therapeutics Inc VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Sarepta Therapeutics Inc and inhibit competitive advantage. This means that the local food products result in competitive parity for Sarepta Therapeutics Inc. As this resource is valuable, Sarepta Therapeutics Inc can still make use of this resource.
- The employees of Sarepta Therapeutics Inc are a rare resource as identified by the VRIO Analysis of Sarepta Therapeutics Inc. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Sarepta Therapeutics Inc are a rare resource as identified by the Sarepta Therapeutics Inc VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Sarepta Therapeutics Inc to use them without interference from the competition.
- The distribution network of Sarepta Therapeutics Inc is a rare resource as identified by the VRIO Analysis of Sarepta Therapeutics Inc. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Sarepta Therapeutics Inc. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Sarepta Therapeutics Inc are costly to imitate as identified by the Sarepta Therapeutics Inc VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Sarepta Therapeutics Inc. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Sarepta Therapeutics Inc provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Sarepta Therapeutics Inc are also not costly to imitate as identified by the Sarepta Therapeutics Inc VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Sarepta Therapeutics Inc by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Sarepta Therapeutics Inc a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Sarepta Therapeutics Inc are very difficult to imitate as identified by the VRIO Analysis of Sarepta Therapeutics Inc. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Sarepta Therapeutics Inc is also very costly to imitate by competition as identified by the Sarepta Therapeutics Inc VRIO Analysis. This has been developed over the years gradually by Sarepta Therapeutics Inc. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Sarepta Therapeutics Inc are organised to capture value as identified by the VRIO Analysis of Sarepta Therapeutics Inc. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Sarepta Therapeutics Inc.
- The Patents of Sarepta Therapeutics Inc are not well organised as identified by the Sarepta Therapeutics Inc VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Sarepta Therapeutics Inc starts selling patented products before the patents expire.
- The distribution network of Sarepta Therapeutics Inc is organised as identified by the VRIO Analysis of Sarepta Therapeutics Inc. Sarepta Therapeutics Inc uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Sarepta Therapeutics Inc.
From the VRIO Analysis of Sarepta Therapeutics Inc, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Sarepta Therapeutics Inc is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Ngoc Han
5.0
The assignment was supplied to me late but it was well explained and even there was no need for the modification that let me submit it without ant further delay. Thanks!
Frankie Cooper
5.0
I can say without hesitation that this service is a perfect choice if you want to reduce the tension of college papers. Good Luck guys!
Jack Eric
5.0
I think that I’ll apply for this service next time. All papers were delivered on time and with high quality. Grateful!
Violet Callum
5.0
The top company for the dissertation needs. I will definitely look for these guys for the future paper.
Next Articles
- Sierra Oncology, Inc. Vrio Analysis
- Sensus Healthcare, Inc. Vrio Analysis
- Strata Skin Sciences, Inc. Vrio Analysis
- SunLink Health Systems, Inc. Vrio Analysis
- STAAR Surgical Company Vrio Analysis
- SteadyMed Ltd. Vrio Analysis
- Steris Plc Vrio Analysis
- Stemline Therapeutics, Inc. Vrio Analysis
- Supernus Pharmaceuticals, Inc. Vrio Analysis
- Sinovac Biotech Ltd. Vrio Analysis
Previous Articles
- Sorrento Therapeutics, Inc. Vrio Analysis
- Surmodics, Inc. Vrio Analysis
- Spectrum Pharmaceuticals, Inc. Vrio Analysis
- SeaSpine Holdings Corporation Vrio Analysis
- The Spectranetics Corporation Vrio Analysis
- Sophiris Bio, Inc. Vrio Analysis
- Span America Medical Systems, Inc. Vrio Analysis
- Sanofi Vrio Analysis
- Sunesis Pharmaceuticals, Inc. Vrio Analysis
- Sonoma Pharmaceuticals, Inc. Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!